Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Jan;69(1):226–230. doi: 10.1172/JCI110434

Inactivation of S-adenosylhomocysteine hydrolase during adenine arabinoside therapy.

S L Sacks, T C Merigan, J Kaminska, I H Fox
PMCID: PMC371186  PMID: 7054240

Abstract

To assess for possible inhibition of cellular transmethylation during adenine arabinoside (ara-A) therapy, S-adenosylhomocysteine hydrolase activity was analyzed in 10 patients with chronic hepatitis B virus infection. In six patients receiving ara-A, enzyme activity was suppressed to 0-2% of control erythrocyte enzyme activity. This decrease in enzyme activity was evident within 4 h of starting the drug infusion and continued for 7 d after cessation of therapy. S-adenosylhomocysteine hydrolase activity of peripheral mononuclear cells was also measured in two patients receiving ara-A. Suppression to as low as 3.5% of pretreatment levels was found; however, marked fluctuations with partial return of enzyme activity during therapy was also observed in mononuclear cells. Inhibition of an enzyme involved in transmethylation reactions was observed in patients during ara-A therapy. This could contribute to the side effects and antiviral properties of ara-A.

Full text

PDF
226

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bader J. P., Brown N. R., Chiang P. K., Cantoni G. L. 3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells. Virology. 1978 Sep;89(2):494–505. doi: 10.1016/0042-6822(78)90191-5. [DOI] [PubMed] [Google Scholar]
  2. Bennett L. L., Jr, Shannon W. M., Allan P. W., Arnett G. Studies on the biochemical basis for the antiviral activities of some nucleoside analogs. Ann N Y Acad Sci. 1975 Aug 8;255:342–358. doi: 10.1111/j.1749-6632.1975.tb29242.x. [DOI] [PubMed] [Google Scholar]
  3. Carson D. A., Kaye J., Seegmiller J. E. Metabolism and toxicity of 9-beta-D-arabinofuranosyladenine in human malignant T cells and B cells in tissue culture. Adv Exp Med Biol. 1979;122B:299–307. doi: 10.1007/978-1-4684-8559-2_49. [DOI] [PubMed] [Google Scholar]
  4. Chiang P. K., Cantoni G. L., Bader J. P., Shannon W. M., Thomas H. J., Montgomery J. A. Adenosylhomocysteine hydrolase inhibitors: synthesis of 5'-deoxy-5'-(isobutylthio)-3-deazaadenosine and its effect on Rous sarcoma virus and Gross murine leukemia virus. Biochem Biophys Res Commun. 1978 May 30;82(2):417–423. doi: 10.1016/0006-291x(78)90892-6. [DOI] [PubMed] [Google Scholar]
  5. Edwards N. L., Gelfand E. W., Burk L., Dosch H. M., Fox I. H. Distribution of 5'-nucleotidase in human lymphoid tissues. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3474–3476. doi: 10.1073/pnas.76.7.3474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fox I. H., Andres C. M., Gelfand E. W., Biggar D. Purine nucleoside phosphorylase deficiency: altered kinetic properties of a mutant enzyme. Science. 1977 Sep 9;197(4308):1084–1086. doi: 10.1126/science.407651. [DOI] [PubMed] [Google Scholar]
  7. Giblett E. R., Anderson J. E., Cohen F., Pollara B., Meuwissen H. J. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972 Nov 18;2(7786):1067–1069. doi: 10.1016/s0140-6736(72)92345-8. [DOI] [PubMed] [Google Scholar]
  8. Hafkin B., Pollard R. B., Tiku M. L., Robinson W. S., Merigan T. C. Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses. Antimicrob Agents Chemother. 1979 Dec;16(6):781–787. doi: 10.1128/aac.16.6.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hershfield M. S. Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine and adenine arabinoside. A basis for direct toxic effects of analogs of adenosine. J Biol Chem. 1979 Jan 10;254(1):22–25. [PubMed] [Google Scholar]
  10. Hershfield M. S., Kredich N. M., Ownby D. R., Ownby H., Buckley R. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients. J Clin Invest. 1979 Apr;63(4):807–811. doi: 10.1172/JCI109367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hirschhorn R., Paageorgiou P. S., Kesarwala H. H., Taft L. T. Amerioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency. N Engl J Med. 1980 Aug 14;303(7):377–380. doi: 10.1056/NEJM198008143030706. [DOI] [PubMed] [Google Scholar]
  12. Jacquemont B., Huppert J. Inhibition of viral RNA methylation in herpes simplex virus type 1-infected cells by 5' S-isobutyl-adenosine. J Virol. 1977 Apr;22(1):160–167. doi: 10.1128/jvi.22.1.160-167.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kaminska J. E., Fox I. H. Decreased S-adenosylhomocysteine hydrolase in inborn errors of purine metabolism. J Lab Clin Med. 1980 Jul;96(1):141–147. [PubMed] [Google Scholar]
  14. Kredich N. M., Hershfield M. S. S-adenosylhomocysteine toxicity in normal and adenosine kinase-deficient lymphoblasts of human origin. Proc Natl Acad Sci U S A. 1979 May;76(5):2450–2454. doi: 10.1073/pnas.76.5.2450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kredich N. M. Inhibition of nucleic acid methylation by cordycepin. In vivo synthesis of S-3'-DEOXYADENOSYLMETHIONINE BY WI-L2 human lymphoblasts. J Biol Chem. 1980 Aug 10;255(15):7380–7385. [PubMed] [Google Scholar]
  16. Kredich N. M., Martin D. V., Jr Role of S-adenosylhomocysteine in adenosinemediated toxicity in cultured mouse T lymphoma cells. Cell. 1977 Dec;12(4):931–938. doi: 10.1016/0092-8674(77)90157-x. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Müller W. E., Zahn R. K., Bittlingmaier K., Falke D. Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems. Ann N Y Acad Sci. 1977 Mar 4;284:34–48. doi: 10.1111/j.1749-6632.1977.tb21935.x. [DOI] [PubMed] [Google Scholar]
  19. Pelling J. C., Drach J. C., Shipman C., Jr Internucleotide incorporation of arabinosyladenine into herpes simplex virus and mammalian cell DNA. Virology. 1981 Mar;109(2):323–335. doi: 10.1016/0042-6822(81)90503-1. [DOI] [PubMed] [Google Scholar]
  20. Pike M. C., Kredich N. M., Snyderman R. Requirement of S-adenosyl-L-methionine-mediated methylation for human monocyte chemotaxis. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3928–3932. doi: 10.1073/pnas.75.8.3928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pugh C. S., Borchardt R. T., Stone H. O. Inhibition of Newcastle disease virion messenger RNA (guanine-7-)-methyltransferase by analogues of S-adenosylhomocysteine. Biochemistry. 1977 Aug 23;16(17):3928–3932. doi: 10.1021/bi00636a032. [DOI] [PubMed] [Google Scholar]
  22. Pugh C. S., Borchardt R. T., Stone H. O. Sinefungin, a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral multiplication. J Biol Chem. 1978 Jun 25;253(12):4075–4077. [PubMed] [Google Scholar]
  23. Scullard G. H., Pollard R. B., Smith J. L., Sacks S. L., Gregory P. B., Robinson W. S., Merigan T. C. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis. 1981 Jun;143(6):772–783. doi: 10.1093/infdis/143.6.772. [DOI] [PubMed] [Google Scholar]
  24. Shipman C., Jr, Smith S. H., Carlson R. H., Drach J. C. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures. Antimicrob Agents Chemother. 1976 Jan;9(1):120–127. doi: 10.1128/aac.9.1.120. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES